Literature DB >> 25599209

Outcomes and prognostic factors after emergent carotid artery stenting for hyperacute stroke within 6 hours of symptom onset.

Woong Yoon1, Byung Moon Kim, Dong Joon Kim, Dong Ik Kim, Seul Kee Kim.   

Abstract

BACKGROUND: The optimal treatment for hyperacute stroke attributable to cervical internal carotid artery (C-ICA) occlusion remains controversial.
OBJECTIVE: This study sought to evaluate clinical outcomes and prognostic factors after carotid artery stenting (CAS) in patients with hyperacute stroke within 6 hours of onset.
METHODS: Forty-seven patients with hyperacute stroke attributable to atherosclerotic C-ICA occlusion underwent emergent CAS. Forty-two patients (89.4%) had tandem intracranial artery occlusion (TIO). When patients showed remnant M1 or proximal M2 occlusions after CAS, intracranial recanalization therapy was performed by using pharmacologic thrombolysis and mechanical thrombectomy with a Solitaire stent. Clinical and radiologic data were compared between patients with favorable (modified Rankin scale, 0-2) and unfavorable outcomes. Binary logistic regression analysis was used to find independent prognostic factors.
RESULTS: Emergent CAS was successful in all but 1 patient. Seven (16.7%) of 42 patients with TIO did not need further treatment, because thrombolysis in cerebral ischemia ≥2b was achieved immediately after CAS. Of the 35 patients who underwent intracranial recanalization therapy for remnant TIO, thrombolysis in cerebral ischemia ≥2b was achieved in 71.4% (25 of 35). Twenty-six patients (55.3%) had favorable outcomes, and mortality was 6.4% at 3 months. Time from symptom onset to carotid recanalization was inversely and independently associated with a favorable outcome for all patients and for those with TIO (P < .05).
CONCLUSION: In our patient group, emergent CAS for hyperacute stroke caused by atherosclerotic C-ICA occlusion seemed to be effective and safe. Time to carotid recanalization was inversely and independently associated with a favorable outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25599209     DOI: 10.1227/NEU.0000000000000610

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Stent-Retriever Thrombectomy for Acute Anterior Ischemic Stroke with Tandem Occlusion: A Systematic Review and Meta-Analysis.

Authors:  Rotem Sivan-Hoffmann; Benjamin Gory; Xavier Armoiry; Mayank Goyal; Roberto Riva; Paul Emile Labeyrie; Anne-Claire Lukaszewicz; Jean-Jacques Lehot; Laurent Derex; Francis Turjman
Journal:  Eur Radiol       Date:  2016-04-16       Impact factor: 5.315

2.  Acute Carotid Artery Stenting Versus Balloon Angioplasty for Tandem Occlusions: A Systematic Review and Meta-Analysis.

Authors:  Cynthia B Zevallos; Mudassir Farooqui; Darko Quispe-Orozco; Alan Mendez-Ruiz; Andres Dajles; Aayushi Garg; Milagros Galecio-Castillo; Mary Patterson; Osama Zaidat; Santiago Ortega-Gutierrez
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

Review 3.  Causes and Solutions of Endovascular Treatment Failure.

Authors:  Byung Moon Kim
Journal:  J Stroke       Date:  2017-05-31       Impact factor: 6.967

Review 4.  Endovascular Stroke Therapy Focused on Stent Retriever Thrombectomy and Direct Clot Aspiration: Historical Review and Modern Application.

Authors:  Dong-Hun Kang; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2017-05-01

5.  Predictors of a Favorable Outcome after Emergent Carotid Artery Stenting in Acute Anterior Circulation Stroke Patients.

Authors:  Gyeong Il Moon; Byung Hyun Baek; Seul Kee Kim; Yun Young Lee; Hyo-Jae Lee; Woong Yoon
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-05-29

Review 6.  Treatment of the extracranial carotid artery in tandem lesions during endovascular treatment of acute ischemic stroke: a systematic review and meta-analysis.

Authors:  Joyce Hellegering; Maarten Uyttenboogaart; Reinoud P H Bokkers; Mostafa El Moumni; Clark J Zeebregts; Maarten J van der Laan
Journal:  Ann Transl Med       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.